Skip to content

Effects of Cultura Yoghurt in Relation to Transit Time and Digestive Discomfort in Healthy Women and Men

Effects of Cultura Yoghurt in Relation to Transit Time and Digestive Discomfort During 2 Weeks of Treatment in Comparison to Placebo in Healthy Women and Men

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01102036
Enrollment
50
Registered
2010-04-12
Start date
2010-02-28
Completion date
2010-06-30
Last updated
2011-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Constipation

Keywords

Transit time, constipation, gut regularity, defecation frequency, Colonic transit time

Brief summary

The aim of this study is to determine the effect of cultura yoghurt on transit time and digestive discomfort during 2 weeks of treatment in comparison to placebo in healthy women and men.

Detailed description

Transit time is the time it takes for a substance to pass through the gut. The major part of the transit is spent in the large bowel is therefore mainly a colonic event. It has been observed that slow transit time is associated with high prevalence of large bowel disorders. The objectives of this study is to: * determine the effect on mean transit time after 2 weeks intake of a investigational products using radio-opaque sulphate impregnated polyethylene pellets as markers. * determine effect of investigational products on total symptom score according to Bristol Stool Form (BSF) * determine effect of investigational products in gastrointestinal symptoms * determine safety of intake of the investigational products

Interventions

OTHERCultura L casei F19, acidophilus La5 , B lactis Bb 12

2 weeks consumption,250 ml/day

OTHERYoghurt without probiotics

Yoghurt without probiotics

Sponsors

Arla Foods
CollaboratorINDUSTRY
Good Food Practice, Sweden
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Female and Males * Healthy * BMI 19-29 at visit 1 * Age 18 and 60 years at visit 1 * Defecation 3-4 times per week or every second to third day (Bristol Stool Form) during the run-in * Transit time 35 and 72 hours calculated from the abdominal X-ray at visit 3 * Signed written informed consent

Exclusion criteria

* Use of probiotics food or supplements during the study * Past history of digestive disease * Previous complicated GI surgery * Oral use of antimicrobial medication or antimicrobial prophylaxis 4 weeks prior to screening visit * Use of laxatives (medication or dietary supplements) during the study. * Pregnant or lactating or wish to become pregnant during the period of the study * Lack of suitability for participation in the trial, for any reason, as judged by the personnel at KPL Good Food Practice AB

Design outcomes

Primary

MeasureTime frameDescription
Change in transit time between treatmentsFebruary 2010-June 2010To determine the effect on mean transit time after 2 weeks intake of investigational products using radio-opaque barium sulphate impregnated polyethylen capsules. These capsules will be consumed during 3 days and thereafter an x-ray image will be taken over the bowel. The capsulese will then be calculated to determine the colonic transit time

Secondary

MeasureTime frameDescription
Change between treatments on Bristol Stool Form (BSF)symptoms scoresFebruary 2010-June2010To determine the effect of Cultura yoghurt on the total symptom score according to Bristol Stool Form (BSF) scale during 2 weeks of treatment in comparison to placebo in healthy women and men
Change between treatments on gastrointestinal symptoms according to Bristol Stool FormFebruary 2010-June 2010To determine the effect of Cultura yoghurt on gastrointestinal symptoms according to the Bristol Stool Form (BSF) after 2 weeks treatment of investigational products

Countries

Sweden

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026